Vanguard Personalized Indexing Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,231
Closed -$768K 1567
2023
Q2
$768K Buy
18,231
+956
+6% +$38.7K 0.02% 700
2023
Q1
$615K Buy
17,275
+10,112
+141% +$367K 0.02% 773
2022
Q4
$263K Buy
+7,163
New +$283K 0.01% 1023
2022
Q3
Sell
-8,297
Closed -$595K 1326
2022
Q2
$595K Buy
8,297
+473
+6% +$34.6K 0.03% 730
2022
Q1
$633K Buy
7,824
+341
+5% +$28.8K 0.03% 707
2021
Q4
$768K Buy
7,483
+3,104
+71% +$298K 0.05% 524
2021
Q3
$383K Sell
4,379
-1,869
-30% -$169K 0.03% 653
2021
Q2
$559K Buy
+6,248
New +$528K 0.06% 430

Other funds holding SYNH

Vanguard Personalized Indexing Management's SYNH Position: Q3 2023 in Review

Vanguard Personalized Indexing Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 18,231 shares — an estimated $768K sold.

Vanguard Personalized Indexing Management first reported a position in SYNH in Q2 2021 and held it in 8 quarters. The position peaked at $768K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Vanguard Personalized Indexing Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 18,231 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $768K.
  • Vanguard Personalized Indexing Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 8 quarters.
  • Vanguard Personalized Indexing Management's Syneos Health, Inc. Class A Common Stock position peaked at $768K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2023, filed 8 Nov 2023.